Untargeted Lipidomics Market
Number of pages: 100 | Report Format: PDF | Published date: May 15, 2023
Historical Years – 2021 | Base Year – 2022 | Forecasted Years – 2023 to 2031
|
Report Attribute |
Details |
|
Market Size Value in 2022 |
US$ 433.58 million |
|
Revenue Forecast in 2031 |
US$ 1421.2 million |
|
CAGR |
14.1% |
|
Base Year for Estimation |
2022 |
|
Forecast Period |
2023 to 2031 |
|
Historical Year |
2021 |
|
Segments Covered |
Application, Platform, End User and Region |
|
Regional Scope |
North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
According to the deep-dive market assessment study by Growth Plus Reports, the global untargeted lipidomics market was valued at US$ 433.58 million in 2022 and is expected to register a revenue CAGR of 14.1% to reach US$ 1421.2 million by 2031.
Untargeted Lipidomics Market Fundamentals
Untargeted lipidomics is a method used to identify and quantify all the lipid molecules present in a biological sample without prior knowledge of their chemical structure. It involves the analysis of complex mixtures of lipids using high-resolution mass spectrometry coupled with liquid chromatography. In untargeted lipidomics, the sample is extracted and then separated using chromatography into individual lipid classes based on their physical and chemical properties. The separated lipids are then ionized and analyzed by mass spectrometry, which generates a mass spectrum containing information about each lipid species' mass and abundance. The resulting data can be analyzed using bioinformatics tools to identify and quantify the different lipid present in the sample. By comparing the mass spectra obtained from different samples, researchers can also identify changes in lipid composition that may be associated with various biological processes or diseases.
The global untargeted lipidomics industry analysis report comprehensively analyzes the market, with the factors that either aid or impede the market growth, such as its drivers, restraints, and opportunities. The research provides insight into the companies that operate in the untargeted lipidomics market and their efforts to position themselves as key players through expansion strategies and innovations. It also highlights recent developments that contribute to the untargeted lipidomics market growth. The research also analyzes the impact of the COVID-19 pandemic.
This research is valuable for businesses seeking insights into the market, customers, and competition. The research provides special insights into the segmentation, regions, market size & projection, revenue CAGRs, and other important information that may help clients make the right decisions. The report assembles data from market players and professionals across the industrial value chain. The study also incorporates qualitative and quantitative assessments from industry professionals. Secondary research, surveys and interviews, and statistical modeling are all used in our research to estimate market size and projection. Our reports deliver the most reliable market data because of our specialized research methods.
[1254]
Untargeted Lipidomics Market Dynamics
Chronic diseases such as diabetes, cardiovascular disease, and cancer are becoming more prevalent, driving the need for better diagnostic tools and treatments, which is a primary driver for the growth of the global untargeted lipidomics market. Untargeted lipidomics can provide insights into the lipid profiles of patients with these diseases, helping to identify potential biomarkers and targets for therapy. For instance, according to the WHO’s factsheet of April 2023, the prevalence of diabetes is rising drastically; the number of diabetic patients rose from 108 million to 442 million from 1980 to 2014. The development of new lipid profiling and analysis technologies, such as high-resolution mass spectrometry, has greatly improved the accuracy and speed of untargeted lipidomics. This has resulted in increased interest and adoption of technology and the growth of the global untargeted lipidomics market. There is a growing demand for personalized medicine, which requires the identification of biomarkers that can be used to develop targeted therapies. Untargeted lipidomics can provide a wealth of information on the lipid profiles of individuals, making it a valuable tool for biomarker discovery.
Additionally, the cost of instrumentation, the complexity of data analysis, and limited sample throughput are some of the restraints impeding the overall untargeted lipidomics market growth.
Untargeted Lipidomics Market Ecosystem
Untargeted Lipidomics Market, by Application
Untargeted Lipidomics Market, by Platform
Untargeted Lipidomics Market, by End User
Untargeted Lipidomics Market by Application
[5858]
The drug research and discovery segment accounts for a significant market revenue share. Untargeted lipidomics is used to identify and characterize lipid molecules involved in various disease processes and discover new drug targets. Using untargeted lipidomics in drug research and discovery allows for identifying lipid molecules that are altered in disease states compared to healthy states. These lipids may be biomarkers for disease diagnosis, monitoring, and prognosis. Moreover, identifying lipid targets for drug development may offer novel therapeutic opportunities.
The market segmentation sections provide the untargeted lipidomics market outlook in terms of the demarcation of different consumer groups. Market segmentation is the split of an industry into subgroups depending on characteristics such as application, platform, and end user. Market segmentation data helps organizations understand the preferences and distinctive demands of different customer groups and implement targeted marketing strategies. This data additionally helps in identifying potential untargeted lipidomics market demand opportunities.
Untargeted Lipidomics Market by Region
North America dominated the global untargeted lipidomics market with the largest revenue share in 2022, owing to the presence of key market players, increasing demand for personalized medicine, and growing research activities in lipidomics. The region has many leading companies, research institutions, and academic centers actively engaged in untargeted lipidomics research and development. Moreover, the increasing prevalence of chronic diseases, such as diabetes, cardiovascular disease, and cancer, is driving demand for untargeted lipidomics-based diagnostics and therapies. For instance, according to the Centers for Disease Control and Prevention’s article of October 2022, in the U.S., every 34 seconds, one person dies due to cardiovascular disease.
Based on the regions, the global untargeted lipidomics market is segmented into:
The industry's regional segmentation provides insights into geographic pockets in terms of untargeted lipidomics industry trends, market size, share, and growth rate. This information helps organizations assess potential growth opportunities in new regional markets, understand competitive threats, and develop localized sales and expansion strategies. This section also offers deeper insights into the regional and country-level untargeted lipidomics market overview.
Key Components of the Report
Untargeted Lipidomics Market Competitive Landscape
The market competitive landscape analysis is performed by gathering and evaluating data about the key competitors, industry trends, and market dynamics. It involves collecting and analyzing data on factors such as products, pricing, geographic reach, customer demographics, marketing tactics, and recent developments. Competitive landscape analysis can help organizations identify present or prospective opportunities and risks in the market.
Untargeted Lipidomics Market Strategic Developments
Reasons To Buy This Report
Key Strengths of Our Report
Target Audience to Benefit from this Report.
Untargeted lipidomics is a method used to identify and quantify all the lipid molecules in a biological sample without prior knowledge of their chemical structure.
The global untargeted lipidomics market was valued at US$ 433.58 million in 2022.
North American region will have the largest untargeted lipidomics market size during the forecast period from 2023 to 2031.
The revenue CAGR of the untargeted lipidomics market during the forecast period will be 14.1 % from 2023 to 2031.
Growing demand for personalized medicine is the most prominent untargeted lipidomics industry trend.
The cost of instrumentation, the complexity of data analysis, and limited sample throughput are some key challenges hampering the growth of the global untargeted lipidomics market.
The increasing prevalence of chronic diseases and technological advancements are growth opportunities in the global untargeted lipidomics market.
Some prominent players in the untargeted lipidomics market are Bruker Corporation, Agilent Technologies Inc., PerkinElmer Inc., Sciex, Metabolon, Inc., and Cayman Chemical.
The application segment has the highest share in the global untargeted lipidomics market.
*Insights on financial performance are subject to the availability of information in the public domain